None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: We enrolled patients who underwent MVD for HFS at our institution between June 2021 and March 2022.
Exclusion criteria
Exclusion criteria: The exclusion criteria were as follows: age <19 years at the time of surgery, history of facial palsy or injections of botulinum toxin within 6 months prior to enrollment, history of MVD or related treatments, secondary HFS due to the presence of an intracranial mass or cyst (as confirmed by brain imaging), underlying diabetes mellitus or amyloidosis causing severe peripheral neuropathy, history of stroke with motor weakness or myoatrophy, neuromuscular junction disease (such as myasthenia gravis), and pregnancy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| latency of lateral spread response | — |
Secondary
| Measure | Time frame |
|---|---|
| Findings of lateral spreading artifact | — |
Countries
Korea, Republic of
Contacts
Konkuk University